C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions

Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
12/2011
12/20/2011	CA2461322C .beta.2 adrenergic polymorphism detection
12/20/2011	CA2449201C Acridone derivatives as labels for fluorescence detection of target materials
12/20/2011	CA2447450C Corona-virus-like particles comprising functionally deleted genomes
12/20/2011	CA2446310C Analytical method and kit
12/20/2011	CA2386858C 36p6d5: secreted tumor antigen
12/20/2011	CA2330245C Cellulase producing actinomycetes, cellulase produced therefrom and method of producing same
12/20/2011	CA2299699C Genetic control of plant growth and development
12/20/2011	CA2297140C Method and devices for detecting and enumerating microorganisms
12/20/2011	CA2252013C Procedure for the detection of high virus concentrations in blood plasma and/or blood serum by means of the polymerase chain reaction
12/15/2011	WO2011156795A2 Nucleic acids for multiplex organism detection and methods of use and making the same
12/15/2011	WO2011156777A1 Use of blood mir-210 for cancer prognosis
12/15/2011	WO2011156763A1 Methods for characterizing kidney function
12/15/2011	WO2011156734A2 Method of characterizing vascular diseases
12/15/2011	WO2011156728A2 Zinc sensors for cellular imaging
12/15/2011	WO2011156707A2 Alternative nucleotide flows in sequencing-by-synthesis methods
12/15/2011	WO2011156690A2 Methods for the development of vaccines based on oligosaccharide-oligonucleotide conjugates
12/15/2011	WO2011156654A2 Pathways characterization of cells
12/15/2011	WO2011156539A2 Compositions and methods for protein production
12/15/2011	WO2011156467A2 Methods of detecting residual amounts of polymers used in the purification of biomolecules
12/15/2011	WO2011156434A2 Nucleic acid detection and quantification by post-hybridization labeling and universal encoding
12/15/2011	WO2011156432A2 Scanning multifunctional particles
12/15/2011	WO2011156430A2 Generation and expression of engineered i-onui endonuclease and its homologues and uses thereof
12/15/2011	WO2011156387A2 Enumeration of nucleic acids
12/15/2011	WO2011156376A1 Transcriptome in vivo analysis
12/15/2011	WO2011156366A2 Fluorogenic sensors for phospholipase c isozymes
12/15/2011	WO2011156258A1 Filtration methods and devices
12/15/2011	WO2011156251A2 Filtration methods and devices
12/15/2011	WO2011156249A2 Yeast concentration and viability measurement
12/15/2011	WO2011156007A2 Rt-lamp assay for the detection of pan-serotype dengue virus
12/15/2011	WO2011155973A2 Modified renilla luciferase nucleic acids and methods of use
12/15/2011	WO2011155833A2 Combinatorial sequence barcodes for high throughput screening
12/15/2011	WO2011155531A1 Prediction of risk of onset of drug-induced pulmonary disorders, and method and kit for detection of gene for the prediction of the risk
12/15/2011	WO2011154940A1 Methods and kits for diagnosing conditions related to hypoxia
12/15/2011	WO2011154689A1 Methods and means for predicting or diagnosing diabetes or cardiovascular disorders based on micro rna detection
12/15/2011	WO2011154662A2 Method for detecting compounds that modulate the cholesterol metabolism
12/15/2011	WO2011154650A2 Method for identifying mammalian cells by maldi-tof mass spectrometry on whole cells
12/15/2011	WO2011154579A1 In vitro diagnostic method for patients with splenic marginal zone lymphoma
12/15/2011	WO2011154570A1 Ghrelin variant and uses thereof
12/15/2011	WO2011154553A2 Novel micrornas for the detection and isolaton of human embryonic stem cell-derived cardiac cell types
12/15/2011	WO2011154517A1 MASS SPECTROMETRIC MEASUREMENT OF β-LACTAMASE RESISTANCES
12/15/2011	WO2011154402A1 Inhibitors of micro-rnas for use for preventing and/or attenuating skin ageing and/or for hydrating skin
12/15/2011	WO2011154139A2 Gene expression markers for predicting response to interleukin-6 receptor-inhibiting monoclonal antibody drug treatment
12/15/2011	WO2011154008A1 Microrna classification of thyroid follicular neoplasia
12/15/2011	WO2011153962A1 Apparatus for single-molecule detection
12/15/2011	WO2011153954A1 Method and device for detecting specific dna sequences
12/15/2011	WO2011153684A1 Method and kit for the prognosis of colorectal cancer
12/15/2011	WO2011153590A1 Use of interferon epsilon in methods of diagnosis and treatment
12/15/2011	WO2011153586A1 Kinase inhibitors
12/15/2011	WO2011132175A3 Novel biomarkers and targets for ovarian carcinoma
12/15/2011	WO2011127527A8 Method and system for detecting regulatory single nucleotide polymorphisms
12/15/2011	WO2011123427A9 Treatment of cancer by inhibiting activity or expression of late sv-40 factor
12/15/2011	WO2011123041A8 Fertilization prediction and promotion
12/15/2011	WO2011100392A3 Methionine gamma lyase-2-aminobutyrate (megl-2abd) and therapeutic uses thereof
12/15/2011	WO2011056060A3 Recombinant matrix protein of nipah virus
12/15/2011	WO2011053257A8 Methods for monitoring cellular states and for immortalizing mesenchymal stem cells
12/15/2011	WO2011020089A3 Target genes for cancer therapy
12/15/2011	US20110307973 Method for producing plants with improved or suppressed blue light recognition capabilities
12/15/2011	US20110307972 Farmesene synthase
12/15/2011	US20110307965 Methods and compositions for detecting canine dilated cardiomyopathy (dcm)
12/15/2011	US20110307964 Mouse having human leukemic stem cell and leukemic non-stem cell amplified therein, and method for production thereof
12/15/2011	US20110306651 Rna interference mediating small rna molecules
12/15/2011	US20110306631 Triple substituted phenanthroline derivatives for the treatment of neurodegenerative or haematological diseases or conditions, or cancer
12/15/2011	US20110306576 Compounds and methods relating thereto
12/15/2011	US20110306570 Na/K-Atpase Expression as an Indicator for the Treatment of Cancer
12/15/2011	US20110306557 Neural regeneration peptides and methods for their use in treatment of brain damage
12/15/2011	US20110306553 Methods and uses involving heme binding protein 1
12/15/2011	US20110306521 Separation of pyrophosphate release and pyrophosphate detection
12/15/2011	US20110306520 Methods, Kits and Compositions Pertaining to the Suppression of the Detectable Probe Binding to Randomly Distributed Repeat Sequences Genomic Nucleic Acid
12/15/2011	US20110306518 Methods and compositions for diagnosing and monitoring transplant rejection
12/15/2011	US20110306517 Reducing irf4, dusp22, or flj43663 polypeptide expression
12/15/2011	US20110306516 Methods for producing induced pluripotent stem cells
12/15/2011	US20110306514 Ratio based biomarkers and methods of use thereof
12/15/2011	US20110306513 Novel biomarker for liver cancer and applications for same
12/15/2011	US20110306512 Gene Expression Profiling for Identification, Monitoring, and Treatment of Osteoarthritis
12/15/2011	US20110306510 Optimized pprobes and primers and methods of using same for the detection, screening, isolating and sequencing of mrsa, mssa staphylococcus markers, and the antibiotic resistance gene mec a
12/15/2011	US20110306509 Compositions and methods for the identification of inhibitors of protein synthesis
12/15/2011	US20110306508 Method of Mycotoxin Detection
12/15/2011	US20110306504 Polynucleotide mapping and sequencing
12/15/2011	US20110306503 Template-dependent nucleic acid polymerization using oligonucleotide triphosphates building blocks
12/15/2011	US20110306111 Redox Polymers
12/15/2011	US20110306098 Compositions and methods for use in isolation of nucleic acid molecules
12/15/2011	US20110306087 Apparatus to analyze a biological sample
12/15/2011	US20110306086 Cell separating method
12/15/2011	US20110306085 Compositions and methods for degrading lignocellulosic biomass
12/15/2011	US20110306084 Tritiated Planar Carbon Forms
12/15/2011	US20110306083 Salt selection of microbial mutants to increase bioproduct tolerance, titer, or osmotic shock tolerance
12/15/2011	US20110306082 "benzoxazole-based fluorescent metal ion indicators"
12/15/2011	US20110306081 Microfluidic Device
12/15/2011	US20110306080 Determination of lamotrigine by mass spectrometry
12/15/2011	US20110306079 Water-dispersable nanoparticles
12/15/2011	US20110306078 Method for Quantitative Transfer of Analytes
12/15/2011	US20110306077 Methods for the detection of alternative cellular energy (ACE) pigments and for monitoring of the ACE pathway in the diagnosis and therapy of diseases
12/15/2011	US20110306076 Cellobiose Dehydrogenase
12/15/2011	US20110306075 Methods related to modified glycans
12/15/2011	US20110306074 Glycosyltransferase reversibility for sugar nucleotide synthesis
12/15/2011	US20110306073 Method and compositions for determining enzymatic activity and specificity of methyltransferases
12/15/2011	US20110306072 Assay test card
12/15/2011	US20110306071 Compositions and Methods for Identifying Substrate Specificity of Inhibitors of Gamma Secretase
12/15/2011	US20110306056 Method of identifying A. baumannii with OXA-131-like drug resistance in diabetic patients
12/15/2011	US20110306055 Method for Detecting Metastasis of GI Cancer

1 ... 532 533 534 535 536 537 538 539 540 541 542 543 544 545 546 547 548 549 550 551 552 ... 3003